|
Existence of a written national strategy or plan that focuses exclusively or primarily on the prevention and control of viral hepatitis:
|
|
yes
|
5 (27.8)
|
3 (23.1)
|
5 (38.5)
|
13 (29.6)
|
|
no
|
13 (78.2)
|
10 (76.9)
|
8 (61.5)
|
31 (70.5)
|
|
If there is a strategy or plan, does it include a surveillance component?
|
| |
N = 5 (%)
|
N = 3 (%)
|
N = 5 (%)
|
N = 13 (%)
|
|
yes
|
5 (100)
|
3 (100)
|
4 (80.0)
|
12 (92.3)
|
|
no
|
0 (0)
|
0 (0)
|
1 (20.0)
|
1 (7.7)
|
|
If there is a strategy or plan, is it exclusive for viral hepatitis or does it also address other diseases?
|
| |
N = 5 (%)
|
N = 3 (%)
|
N = 5 (%)
|
N = 13 (%)
|
|
exclusive for viral hepatitis
|
1 (20.0)
|
1 (33.3)
|
2 (40.0)
|
4 (30.8)
|
|
only for HBV
|
0 (0)
|
1 (33.3)
|
0 (0)
|
1 (7.7)
|
|
only for HCV
|
1 (20.0)
|
0 (0)
|
0 (0)
|
1 (7.7)
|
|
integrated with other diseases
|
3 (60.0)
|
1 (33.3)
|
3 (60.0)
|
7 (53.8)
|
